EBiSC

EBiSC

Details

EwC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Edelweiss Connect (5 days ago)
See why @wepredic @Biopredic_Intl #HepaRG™ cell model is the best for NAFLD investigations #SaferWorldbyDesign… https://t.co/pzgJbUhY7d
Edelweiss Connect (5 days ago)
Among the few in vitro models proposed to mimic steatosis and its progression, the #HepaRG™ cell model has been a s… https://t.co/XpAVqrKDa2
Edelweiss Connect (5 days ago)
RT @CORDIS_EU: Can we have safe science without #AnimalTesting? A method called induced pluripotent stem cells was the focus of the @in3i…
Edelweiss Connect (6 weeks ago)
This #SaferWorldbyDesign blog post presents a collection of perspectives that elaborate our vision of reliable and… https://t.co/qf47C4UnQD
Edelweiss Connect (2 months ago)
Upcoming #SaferWorldbyDesign webinar October 12 Maieutix, based in Basel, Switzerland, will present a series of c… https://t.co/uHtp1QSNNc

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA